Preventing aristolochic acid nephropathy

Clinical Journal of the American Society of Nephrology

Volumn 10, Issue 2, 2015, Pages 167-168

  Anandagoda, Nelomi ^a,b   Lord, Graham M ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARISTOLOCHIC ACID; PROTEIN P53;

ANEMIA; ARISTOLOCHIA; ARISTOLOCHIC ACID NEPHROPATHY; ARTICLE; ASARUM; BALKAN ENDEMIC NEPHROPATHY; BLADDER CARCINOMA; CARCINOGEN DNA INTERACTION; CHINESE MEDICINE; COMPUTER ASSISTED TOMOGRAPHY; CYSTOSCOPY; DISEASE COURSE; DISEASE SURVEILLANCE; ECHOGRAPHY; ENVIRONMENTAL EXPOSURE; GENETIC SUSCEPTIBILITY; HUMAN; INTERSTITIAL NEPHRITIS; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY FUNCTION; NEPHROURETERECTOMY; PHYTOCHEMISTRY; URETEROSCOPY; UROGENITAL TRACT TUMOR; ADVERSE EFFECTS; AGRICULTURE; CHEMICALLY INDUCED; DIET; DRUG EFFECTS; FEMALE; FOOD CONTAMINATION; KIDNEY PROXIMAL TUBULE; MALE; MIGRANT; OCCUPATIONAL DISEASE; OCCUPATIONAL EXPOSURE;

AGRICULTURAL WORKERS' DISEASES; AGRICULTURE; ARISTOLOCHIC ACIDS; BALKAN NEPHROPATHY; DIET; EMIGRANTS AND IMMIGRANTS; FEMALE; FOOD CONTAMINATION; HUMANS; KIDNEY TUBULES, PROXIMAL; MALE; OCCUPATIONAL EXPOSURE;

EID: 84923812873     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.12391214     Document Type: Article

References (20)

1. Vanherweghem J L, Tiedemann C, Abramowitz D, Depierreux M, Vanhaelen-Fastre R, Vanhaelen M, Dratwa M, Richard C, Vandervelde D, Verbeelen D, Jadoul M: Rapidly progressive interstitial renal fibrosis in young women: Association with slimming regimen including Chinese herbs. Lancet 341: 387–391, 1993.
2. Lord GM, Tagore R, Cook T, Gower P, Pusey CD: Nephropathy caused by Chinese herbs in the UK. Lancet 354: 481–482, 1999.
3. WorldHealth Organisation International Agency for Research on Cancer: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Some Traditional Herbal Medicines, Some Mycotoxins, Naphthalene and Styrene, Lyon, France, IARC Press, 2002, p 82.
4. Lord GM, Cook T, Arlt VM, Schmeiser HH, Williams G, Pusey CD: Urothelial malignant disease and Chinese herbal nephropathy. Lancet 358: 1515–1516, 2001.
5. Ivić M: Etiology of endemic nephropathy. Lijec Vjesn 91: 1273–1281, 1969.
6. Hranjec T, Kovac A, Kos J, Mao W, Chen JJ, Grollman AP, Jelaković B: Endemic nephropathy: The case for chronic poisoning by aristolochia. Croat Med J 46: 116–125, 2005.
7. Arlt VM, Ferluga D, Stiborova M, Pfohl-Leszkowicz A, Vukelic M, Ceovic S, Schmeiser HH, Cosyns JP: Is aristolochic acid a risk factor for Balkan endemic nephropathy-associated urothelial cancer? Int J Cancer 101: 500–502, 2002.
8. Arlt VM, Stiborová M, vom Brocke J, Simões ML, Lord GM, Nortier JL, Hollstein M, Phillips DH, Schmeiser HH: Aristolochic acid mutagenesis: Molecular clues to the aetiology of Balkan endemic nephropathy-associated urothelial cancer. Carcinogenesis 28: 2253–2261, 2007.
9. Grollman AP, Shibutani S, Moriya M, Miller F, Wu L, Moll U, Suzuki N, Fernandes A, Rosenquist T, Medverec Z, Jakovina K, Brdar B, Slade N, Turesky RJ, Goodenough AK, Rieger R, Vukelić M, Jelaković B: Aristolochic acid and the etiology of endemic (Balkan) nephropathy. Proc Natl Acad Sci U S A 104: 12129–12134, 2007.
10. Gökmen MR, Lord GM: Aristolochic acid nephropathy. BMJ 344: e4000, 2012.
11. Gökmen MR, Cosyns JP, Arlt VM, Stiborova´ M, Phillips DH, Schmeiser HH, Simmonds MS, Cook HT, Vanherweghem JL, Nortier JL, Lord GM: The epidemiology, diagnosis, and management of aristolochic acid nephropathy: A narrative review. Ann Intern Med 158: 469–477, 2013.
12. Debelle FD, Vanherweghem JL, Nortier JL: Aristolochic acid nephropathy: A worldwide problem. Kidney Int 74: 158–169, 2008.
13. Nortier JL, Schmeiser HH, Muniz Martinez MC, Arlt VM, Vervaet C, Garbar CH, Daelemans P, Vanherweghem JL: Invasive urothelial carcinoma after exposure to Chinese herbal medicine containing aristolochic acid may occur without severe renal failure. Nephrol Dial Transplant 18: 426–428, 2003.
14. Martinez MC, Nortier J, Vereerstraeten P, Vanherweghem JL: Steroid therapy in chronic interstitial renal fibrosis: the case of Chinese-herb nephropathy. Nephrol Dial Transplant 17: 2033– 2034, 2002.
15. Vanherweghem JL, Abramowicz D, Tielemans C, Depierreux M: Effects of steroids on the progression of renal failure in chronic interstitial renal fibrosis: a pilot study in Chinese herbs nephropathy. Am J Kidney Dis 27: 209–215, 1996.
16. Vaclavik L, Krynitsky AJ, Rader JI: Quantification of aristolochic acids I and II in herbal dietary supplements by ultra-highperformance liquid chromatography-multistage fragmentation mass spectrometry. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 31: 784–791, 2014.
17. US Food and Drug Administration: Dietary Supplements: Arsitolochic Acid, US Food and Drug Administration, 2001. Available at: http://www.fda.gov/Food/RecallsOutbreaksEmergencies/SafetyAlertsAdvisories/ucm096388.htm. Accessed December 12, 2014.
18. Stefanovic V, Toncheva D, Atanasova S, Polenakovic M: Etiology of Balkan endemic nephropathy and associated urothelial cancer. Am J Nephrol 26: 1–11, 2006.
19. Jelaković B, Vuković Lela I, Karanović S, Dika Z, Kos J, Dickman K, Sekoranja M, Poljićanin T, Mišić M, Premužić V, Abramović M, Matijević V, Miletić Medved M, Cvitković A, Edwards K, Fućek M, Leko N, Teskera T, Laganovic M, Čvorisˇćec D, Grollman AP: Chronic dietary exposure to aristolochic acid and kidney function in native farmers from a Croatian endemic area and Bosnian immigrants. Clin J Am Soc Nephrol 10: 215–223, 2015.
20. Nortier JL, Martinez MC, Schmeiser HH, Arlt VM, Bieler CA, Petein M, Depierreux MF, De Pauw L, Abramowicz D, Vereerstraeten P, Vanherweghem JL: Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N Engl J Med 342: 1686–1692, 2000.